Breathing assistance apparatus

Information

  • Patent Grant
  • 9974914
  • Patent Number
    9,974,914
  • Date Filed
    Wednesday, July 16, 2014
    10 years ago
  • Date Issued
    Tuesday, May 22, 2018
    6 years ago
Abstract
In one embodiment, a nasal cannula is shaped to fit within a user's nares, where the nasal cannula includes at least one prong allowing high flow delivery of humidified gases and creates positive airway pressure in the patient's airway. The prongs have angled ends such that, in use, gases flowing through the prongs are directed to the user's nasal passages. The nasal cannula body is partially swivelling and preferably has a ball joint connector. In another embodiment the nasal cannula may have at least one flared end prong that preferably seals within a patient's nare.
Description
INCORPORATION BY REFERENCE TO ANY PRIORITY APPLICATIONS

Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated by reference under 37 CFR 1.57.


BACKGROUND OF THE INVENTION

Field of the Invention


The present invention relates to apparatus for treating sleep apnoea. More specifically, the present invention provides a nasal positive airway pressure device.


Description of the Related Art


Obstructive Sleep Apnoea (OSA) is a sleep disorder that affects up to at least 5% of the population in which muscles that normally hold the airway open relax and ultimately collapse, sealing the airway. The sleep pattern of an OSA sufferer is characterised by repeated sequences of snoring, breathing difficulty, lack of breathing, waking with a start and then returning to sleep. Often the sufferer is unaware of this pattern occurring. Sufferers of OSA usually experience daytime drowsiness and irritability due to a lack of good continuous sleep.


In an effort to treat OSA sufferers, a technique known as Continuous Positive Airway Pressure (CPAP) was devised. A CPAP device consists of a gases supply (or blower) with a conduit connected to supply pressurised gases to a patient, usually through a nasal mask. The pressurised air supplied to the patient effectively assists the muscles to keep the patient's airway open, eliminating the typical OSA sleep pattern.


The procedure for administering CPAP treatment has been well documented in both the technical and patent literature. Briefly stated, CPAP treatment acts as a pneumatic splint of the airway by the provision of a positive pressure, usually in the range 4 to 20 cm H.sub.2O. The air is supplied to the airway by a motor driven blower whose outlet passes via an air delivery hose to a nose (or nose and/or mouth) mask sealingly engaged to a patient's face by means of a harness or other headgear. An exhaust port is provided in the delivery tube proximate to the mask. More sophisticated forms of positive airway pressure devices, such as bi-level devices and auto-titrating devices, are described in U.S. Pat. No. 5,148,802 of Respironics, Inc. and U.S. Pat. No. 5,245,995 of Rescare Limited, respectively.


U.S. Pat. No. 5,477,852 of Airways Ltd, Inc. discloses a nasal positive airway pressure device that has a pair of nasal members each having a cannula tip to be inserted into the nares of the patient. Each cannula is tapered from a substantially circular cross-section outside the patient's nostril to a substantially oval cross-section at the tip inserted into the nostril. An inflatable cuff surrounds each cannula with the interior space of the cuff communicating with the lumen of the cannula through at least one aperture in the sidewall of the cannula. The nasal members are connected to one or more flexible hoses that, in turn, are connected to a source of positive air pressure. In use, positive air pressure is supplied to each cannula tip through the air hoses and nasal members. The positive air pressure inflates the cuffs to hold the nasal members in place and to effect treatment. The nasal device of U.S. Pat. No. 5,477,852 is attached to headgear that is located about a patient's head; this headgear could be considered by many patients as cumbersome and uncomfortable.


Conventional nasal masks used for administrating CPAP treatment are also considered uncomfortable and cumbersome, and prior art nasal masks and the like are noisy (due to air leaks). These disadvantages in many cases are a formidable obstacle to patient acceptance of such treatment. Therefore, a substantial number of patients either cannot tolerate treatment or choose to forego treatment. It is believed a substantial number of such patients could benefit from a nasal positive airway pressure apparatus that is more convenient to use and comfortable to wear, thereby resulting in increased treatment compliance.


As oxygen is supplied as a dry gas it is well known in the art to either heat and/or humidify gases before delivering them for breathing by a patient. In particular when delivering oxygen, or oxygen or air mixture, it has proven beneficial to humidify the gases first. In WO01/41854 of Vapotherm, Inc. a system is disclosed that allows the delivery of humidified oxygen through a nasal cannula. This system uses a narrow bore conduit and nasal cannula with a high resistance to gas flows, thereby requiring the oxygen be of a high pressure. Air, as well as oxygen can also be passed down the conduit and nasal cannula and it too must be of a high pressure. This system allows the delivery of high flows of oxygen enriched air to the patient, but is limited in the flows achievable due to the narrow bore of the cannula resulting in high resistance gas flow and excessive velocity and noise upon exiting the cannula. Furthermore, the narrowness of the nasal cannula in this system allows easy expiration of gases between the prongs and nares and therefore does not create any positive airway pressure.


Innomed Technologies, Inc. manufactures a nasal cannula device called the NASALAIRE™. In this device air or oxygen travels down a wide bore conduit to nasal cannula. The NASALAIRE™ creates a physical seal between the nares and itself, and relies on the absence of leaks around itself and the nares to deliver pressure supplied by a continuous positive airway pressure (CPAP) blower to the airway of the wearer.


SUMMARY OF THE INVENTION

It is an object of the present invention to provide a breathing assistance apparatus which goes someway to overcoming the above mentioned disadvantages or which will at least provide the public a useful choice.


Accordingly in a first aspect the present invention consists in a breathing assistance apparatus comprising:

    • nasal cannula, shaped to fit within a user's nares, and adapted to deliver said humidified gases to said user,
    • a pressurised source of gases,
    • transportation means adapted to, in use, be in fluid communication with said source of gases and said nasal cannula and adapted to in use convey said gases to said user,
    • wherein said nasal cannula including at least one prong allowing high flow delivery of said humidified gases and creating a positive airway pressure in said patient's airway, said at least one prong having an angled end, such that in use, gases flowing through said prong are directed to said user's nasal passages.


In a second aspect the present invention consists in a breathing assistance apparatus comprising:

    • nasal cannula, shaped to fit within a user's nares,
    • a pressurised source of gases,
    • transportation means adapted to, in use, be in fluid communication with said source of gases and said nasal cannula and adapted to in use convey said gases to said user,
    • wherein said nasal cannula are adapted to deliver said humidified gases to said user, said nasal cannula including at least one prong allowing high flow delivery of said humidified gases and creating positive airway pressure in said patient's airway, said at least one prong having an end that is flared outwardly.


To those skilled in the art to which the invention relates, many changes in construction and widely differing embodiments and applications of the invention will suggest themselves without departing from the scope of the invention as defined in the appended claims. The disclosures and the descriptions herein are purely illustrative and are not intended to be in any sense limiting.





BRIEF DESCRIPTION OF THE DRAWINGS

Preferred forms of the present invention will now be described with reference to the accompanying drawings.



FIG. 1 is a block diagram of a system providing humidified continuous positive airway pressure to a user as might be used in conjunction with a nasal cannula of the present invention.



FIG. 2 is a perspective view of a first embodiment of the nasal cannula of the present invention.



FIG. 3 is a side view of the nasal cannula of FIG. 2.



FIG. 4 is a plan view of the nasal cannula of FIG. 2.



FIG. 5 is a prong end view of the nasal cannula of FIG. 2



FIG. 6 is an exploded view of the nasal cannula of FIG. 2.



FIG. 7 is a side view of a second embodiment of a nasal cannula of the present invention.



FIG. 8 is a side view of a third embodiment of a nasal cannula of the present invention.



FIG. 9 is a perspective view of a fourth embodiment of a nasal cannula of the present invention.



FIG. 10 is a side view of the nasal cannula of FIG. 9.



FIG. 11 is an exploded perspective view of the nasal cannula of FIG. 9.



FIG. 12 is a front view of the prongs of the nasal cannula of FIG. 9.



FIG. 13 is an exploded side view of the nasal cannula of FIG. 9.



FIG. 14 is a side cross-sectional view of a fifth embodiment of the nasal cannula of the present invention where the connection between a body part and connector of the cannula includes a plurality of channels.



FIG. 15 is a cross-section through AA of the nasal cannula of FIG. 14.



FIG. 16 is a side cross-sectional view of a sixth embodiment of the nasal cannula of the present invention including a shield that protects an outlet vent from inlet gases.



FIG. 17 is a cross-section through BB of the nasal cannula of FIG. 16.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

Whether used in a hospital environment or in a home environment, the nasal cannula of the present invention will generally have associated three main pieces of apparatus. Firstly, an active humidifier, which that controls the temperature of a heater plate heating a body of water to achieve a desired temperature and humidity of the gases being humidified. Secondly, a transport conduit from the humidifier to the patient is also required, which is preferably heated to reduce condensation, or “rain out”. Thirdly, a cannula designed to fit into the nasal cavity and deliver humidified, pressurized gases. In particular, in one embodiment the nasal cannula of the present invention has two flared end prongs that seal within a patient's nares, although in some embodiments the cannula may have a single prong. The cannula prongs are shaped such that a step is created between them so that the prongs abut the user's nasal septum in use. Furthermore, the gripping action of the sides of the prongs to the user's septum in use prevents the prongs from dislodging from the user's nares. In another embodiment the prongs of the nasal cannula are angled toward one another as well as having an angled profile at the outlet of gases, such that gases flow from the prongs flows back into the nasal passage and is not forced up into the rest of the nasal cavity.


With reference to FIG. 1 a humidified Continuous Positive Airway Pressure (CPAP) system is shown in which a patient 1 is receiving humidified and pressurised gases through the nasal cannula 2 of the present invention. The cannula 2 is connected to a humidified gases transportation pathway or inspiratory conduit 3. It should be understood that delivery systems could also be VPAP (Variable Positive Airway Pressure) and BiPAP (Bi-level Positive Airway Pressure) or numerous other forms of respiratory therapy. Inspiratory conduit 3 is connected to the outlet 4 of a humidification chamber 5 that contains a volume of water 6. The inspiratory conduit 3 may contain heating means or heater wires (not shown) which heat the walls of the conduit to reduce condensation of humidified gases within the conduit. The humidification chamber 6 is preferably formed from a plastics material and may have a highly heat conductive base (for example an aluminium base) which is in direct contact with a heater plate 7 of humidifier 8. The humidifier 8 is provided with control means or electronic controller 9 that may comprise a microprocessor based controller executing computer software commands stored in associated memory.


The controller 9 receives input from sources such as user input means or dial 10 through which a user of the device may, for example, set a predetermined required value (preset value) of humidity or temperature of the gases supplied to patient 1. The controller may also receive input from other sources; for example, temperature and/or flow velocity sensors 11 and 12 through connector 13 and heater plate temperature sensor 14. In response to the user set humidity or temperature value input via dial 10 and the other inputs, controller 9 determines when (or to what level) to energise heater plate 7 to heat the water 6 within humidification chamber 5. A flow of gases (for example air) is provided to the chamber through inlet 16 from a gases supply means or blower 15. As the volume of water 6 within humidification chamber 5 is heated, water vapour begins to fill the volume of the chamber above the water's surface and is passed out of the humidification chamber 5 through outlet 4. Exhaled gases from the patient's mouth are passed directly to ambient surroundings in FIG. 1.


The blower 15 is provided with variable pressure regulating means or a variable speed fan 20 which draws air or other gases through the blower inlet 17. The speed of the variable speed fan 20 is controlled by the electronic controller 18 (or alternatively the function of the controller 18 could carried out by the controller 9) in response to inputs from the controller 9 and a user set predetermined required value (preset value) of pressure or fan speed via the dial 19.


Flared Prong Nasal Cannula


A first embodiment of a nasal cannula of the present invention is shown in detail in FIGS. 2 to 6. Referring to FIGS. 2 and 6, the nasal cannula 2 comprises three main components; the prong part 21, body part 22 and ball connector 23.


The prong part 21 has two nasal prongs 24, 25, each of which are substantially shaped to follow the contours of the human nares and in use are placed inside a user's nares. The prongs 24, 25 extend out from a hollow tubular body 26 that in use fits to the body part 22. Each of the prongs 24, 25 are integrally moulded with the tubular body 26 in a flexible plastics material or rubber, such as silicone, other thermoset elastomers or thermoplastic elastomers such as Kraton™. The prongs 24, 25 are substantially oval tubular members that allow for a passage of gases. In particular, as shown in FIG. 5, the prongs are oval in shape and angled in the same manner as a human's nares. The prongs 24, 25 are angled toward one another (or toward the vertical axis Y) at the top 27, 28 of the prongs and away from one another at the bottom 29, 30 of the prongs. Furthermore, the ends 31, 32 of the prongs flare outwardly and preferably are formed such that the ends of the prongs are thinner in cross-section than the rest of the prongs. The flared thinner section ends 31, 32 of the prongs assist with the sealing of the prongs 24, 25 in use within the user's nares. When in use and with gases flowing through the prongs the force of the gas pressure will force the prong ends 31,32 to flare outwardly and seal against the inside of the user's nares.


The prongs 24, 25 each include a step 33, 34 formed along their lengths. Each of the steps 33, 34 are formed on the prongs 24, 25 in an opposing manner such that in use, when the prongs are within a user's nares the steps 33, 34 abut the user's nasal septum and form a ledge that prevents dislodgement of the prongs. The prongs 24, 25 also have protrusions 35, 36 formed on their outer edges that abut the sides of the user's nares (opposite to the nasal septum). The protrusions 35, 36 assist in preventing the dislodgement of the prongs, especially if the user moves his or her head. The protrusions 35, 36 also maintain the prongs within the user's nares in a correct orientation such that in use gases flow through the prongs and directly up the user's nasal passages.


The body part 22 is a tubular passageway in which the prong part 21 is connected at one end and a ball joint 37 at the other end. The ball joint 37 extends from the connector 23 and slots into a complementary shaped (partial sphere) socket end 39. The body part 22 also has a number of apertures 38 formed in it, which act as a bias flow outlet vent. Therefore, any gases exhaled by the user through their nose will exit through the apertures 38.


The connector 23 is preferably connected to the inspiratory conduit 3 (see FIG. 1) that supplies gases flow to the cannula 2. The inspiratory conduit 3 may be moulded directly to the connector 23 or other connection mechanisms may be used, such as a friction fit formed between the connector and conduit.


Although a ball and socket joint, as described above, between the body part 22 and connector 23 is preferred other connections may be utilised, such as a flexible piece of silicone, or other appropriate connection. The connection between the cannula body and connector must be able to be flexed or rotated to allow for the inspiratory conduit 3 to be moved without causing the dislodgement of the nasal cannula 2 from the user's nares.


In the preferred form of the nasal cannula 2 of the present invention the body part 22 and connector 23 are preferably made from a hard or rigid plastics material, such as polypropylene, polycarbonate or acetyl. In other forms the body part 22 and connector 23 may be of different plastics materials to allow for increased slidability between these parts.


The prong part 21 may be supplied in various different sizes such that different sized user's may remove an existing prong part and simply attach a different sized flexible plastics prong part over the body part 22.


To provide additional comfort for the user or ensure the nasal cannula of the present invention do not fall from a user's nares, the nasal cannula may be used in combination with a headgear strap, which in one embodiment is a small flexible tube. For example, FIG. 1 shows a headgear strap 40 extending from the nasal cannula 2. The ends of the headgear strap that attach to the cannula may attach to extensions (or loops) 41 on the body part 22 of the cannula shown in FIG. 2, or may attach about other appropriate areas of the cannula, for example, about the connector 23.


The abovementioned embodiment of the nasal cannula 2 of the present invention is preferably a wide bore pronged cannula used for high flow conditions.


A second embodiment of the present invention is shown in FIG. 7. In this embodiment of the nasal cannula 42 the prongs 43, 44 are preferably small bore prongs for use with lower flow conditions. The prongs 43, 44 are similarly shaped to the prongs 24, 25 detailed above, but may not seal in the same manner as the abovementioned prongs due to the smaller size of the prongs. In fact these prongs may not seal at all in use within the user's nares.


Furthermore, in this second embodiment the nasal cannula 42 is smaller and weighs less as it is only comprised of a prong body 45 and prongs 43, 44, where the body 45 is connected to a small tube that is formed with corrugations or bellows 48 that connect to an inspiratory tube or conduit 47 (similar to the inspiratory conduit 3 described above) that receives a supply of gases.


The corrugations of bellows 48 will bend or move when a weight or force is placed on the cannula, thereby preventing dislodgement of the cannula 42 from a user's face in use. In particular, the corrugations or bellows 48 prevent transferral of the torque onto the cannula 42 when a user moves his or her head.


The body 45 of the cannula 42 is provided with a number of apertures 46 that allows for gases exhaled by the users to be expelled into the ambient air.


The prong body and prongs of this embodiment of the cannula of the present invention are preferably formed a flexible plastics material or rubber, such as silicone, other thermoset elastomers or thermoplastic elastomers such as Kraton™.


A third embodiment of the nasal cannula of the present invention is shown in FIG. 8 where the cannula may be provided with corrugated or baffled sections on the prongs. The nasal cannula 49 of this embodiment is similar to that of FIG. 2 but the prongs 50, 51 have a series of corrugations 52, 53 formed in them. The corrugations 52, 53 allow for movement of each of the prongs 50, 51 for a better user fit, and allow for movement of the cannula 49 without causing dislodgement of the prongs from the user's nares.


Angled Prong Nasal Cannula


A fourth embodiment of the nasal cannula of the present invention is shown in FIGS. 9 to 13. The nasal cannula 60 has a similar construction to the nasal cannula of FIG. 2 and comprises three main components; a prong part 61, body part 62 and ball jointed connector 63.


The prong part 61 preferably has two nasal prongs 64, 65, each of which are substantially shaped to follow the contours of the human nares and in use are placed inside a user's nares. In some forms a cannula with only one prong may be provided. The prongs 64, 65 extend out from a hollow tubular body 66 that in use fits to the body part 62, preferably about an extension 67 (as shown in the exploded view of the nasal cannula of FIG. 11). Each of the prongs 64, 65 are integrally moulded with the tubular body 66 in a flexible plastics material or rubber, such as silicone, other thermoset elastomers or thermoplastic elastomers, such as Kraton™. The prongs 64, 65 are substantially oval tubular members that allow for a passage of gases.


In particular, as shown in FIG. 12, the prongs are oval in shape (to reflect the shape of human nares) and angled in the same manner as a human's nares. The prongs 64, 65 are angled toward one another (or toward the horizontal axis X) such that angles .alpha. are formed between the midlines m, n through each respective prong 64, 65. The angled profile of the prongs 64, 65 means that they are more ergonomically correct with a human's nares and may assist in directing the gases flow from the prongs to the user's nasal cavities. The prongs 64, 65 are constructed such that their cross-sectional width narrows closer to the tip of each prong.


In the preferred form the prongs 64, 65 have an angled and profiled end 76 (see FIG. 10). The angled ends 76 assist in directing gases flow to the user's nasal passages.


Each of the prongs 64, 65 has a flange 73, 74 disposed about its circumference. The flanges 73, 74 are at a position on the prongs 64, 65 such that the each of the flanges rests against the outside of each of the patient's nares. The flanges 73, 74 do not extend inside the nares, but rest at the entranceway of the user's nares, and preferably seal the nares. In some users the flanges 73, 74 may extend within the user's nares and provide sealing of the nares. The flanges 73, 74 are preferably thin flexible extensions that extend substantially completely around the circumference of the prongs 64, 65. The flanges 73, 74 are preferably substantially elliptical in shape with one side (for example, side 89, which in use will abut the nasal septum of a user) of the flange extending out from each prong further than the other side of each prong. There is a recessed area 88 on each of the prongs between the flange and the shaped ends of the prongs in which preferably in use the ends of a user's nares rest.


The body part 62 is a tubular passageway in which the prong part 61 is connected at one end and a ball joint 69 at the other end. The ball joint 69 extends from the connector 63 and slots into a complementary shaped (partial sphere) socket end 70 on the body part 62. The body part 62 may also have a plurality of apertures 71 formed in it, which acts as a bias flow outlet vent. Therefore, any gases exhaled by the user through their nose will exit through the apertures 71.


A shield 75 (illustrated by the dashed line in FIG. 10) may extend over the bias vent 71 inside the body part 70 to prevent gases from the blower (gases supply 15) from interacting with the bias vent 71 and vent holes, causing noise in use.


In a sixth embodiment as shown in FIGS. 16 and 17 a nasal cannula without a prong part is shown, but that includes a shield similar to that described above. In this embodiment a body part 90 and a ball jointed connector 91 fit together as described above. The body part 90 includes an expiratory vent shield 92 that extends down from the top wall 94 of the body part 90 and shields the outlet vent 93.


Referring back to FIGS. 10 to 13, preferably the ball joint connector 63 is angled and extends into a swivelable connector 68. The swivel connector 68 is capable in use of being connected to the inspiratory conduit 3 (see FIG. 1) that supplies gases flow to the cannula 60. The inspiratory conduit 3 may be moulded directly to the connector 68 or other connection mechanisms may be used, such as a friction fit formed between the connector 68 and the conduit 3.


In other forms of the present invention the ball joint connector 63 or the ball joint 69 may have formed in it a plurality of channels. One example of this is the embodiment of FIGS. 14 and 15. Such channels allow there to be a leak when gases flow through the connector to the cannula and prongs. The channels are therefore capable of acting as a bias flow and a separate bias flow out outlet (such as that outlet 71 described above) may not be required.


In FIGS. 14 and 15 only a body part 82 and ball jointed connector 83 are shown. The body part 82 and ball jointed connector 83 join in a manner as described above, where the substantially half sphere shaped end 84 of the body part 82 receives the substantially half sphere shaped end 85 of the connector 83. The ends 84, 85 enable a rotation between the body part 82 and connector 83. In this embodiment two channels 86, 87 are formed in the connector end 85. Two channels are shown in this embodiment but there may be only one or any number of channels. Similarly, channels may be formed in the body part end 84.


It is preferred that there is a ball and socket joint, as described above, between the body part 62 and connector 63, although other connections may be utilised, such as a flexible piece of silicone, or other appropriate connection. The connection between the cannula body and connector must be able to be flexed or rotated to allow for the inspiratory conduit 3 to be moved without causing the dislodgement of the nasal cannula 60 from the user's nares.


In the preferred form of the nasal cannula 60 of the present invention the body part 62, connector 63, ball joint 69 and swivel connector 68 are preferably made from a hard or rigid plastics material, such as polypropylene, polycarbonate or acetyl. In other forms these may be of different plastics materials to allow for increased slidability between these parts.


The prong part 61 may be supplied in various different sizes such that different sized user's may remove an existing prong part and simply attach a different sized flexible plastics prong part over the body part 62.


To provide additional comfort for the user or ensure the nasal cannula of the present invention does not fall from a user's nares, the nasal cannula 60 is preferably used in combination with a headgear strap. The strap may be similar to that shown in FIG. 1 with relation to the first form of the nasal cannula 2. In this fourth form of the nasal cannula 60 the body part 62 has headgear extensions 72, 73 that extend out from the body part 70. The extensions 72, 73 each have a channel 77, 78 formed in them that is capable of receiving an end 80, 81 of the headgear strap 79. The strap ends 80, 81 in use are threaded through apertures (preferably two) and extend into and are held in the channels 77, 78. In this form the headgear strap 79 is made from a small diameter silicon, rubber or similar type material. Therefore, when the strap ends 80, 81 are threaded through the apertures friction is created that maintains the straps within the apertures and prevents the straps from slipping from the cannula.


In other forms the ends of the headgear strap that attach to the cannula may attach to extensions (or loops) 41 on the body part 22 of the cannula shown in FIG. 6, or may attach about other appropriate areas of the cannula, for example, about the connector 23.

Claims
  • 1. A nasal cannula configured to deliver humidified gases to a user, the nasal cannula comprising: a prong part comprising a prong part body having a first end with two openings, a second end with a single opening, and two prongs extending from the two openings, respectively and integrally formed with the first end and the second end, the two prongs spaced from each other and shaped to fit within nares of a user in use, the second end being disposed opposite the first end along a central axis extending through the first and second ends, the prong part body comprising an outer surface extending around the central axis and between the first and second ends, the outer surface having at least a first portion and a second portion, the first portion facing toward a user's face in use and the second portion facing away from a user's face in use, the first portion comprising a curved segment disposed between the first and second ends and curving inwardly toward an interior of the prong part body; anda body part having a first end and a second end, wherein the second end of the prong part body is configured to be connected to the first end of the body part, and the second end of the body part is configured to be coupled to a conduit configured to supply humidified gases to the nasal cannula, the body part further comprising an outer surface having at least a user-side portion facing toward a user's face in use, the user-side portion comprising a curved part, curving inward toward an interior of the body part;wherein the two prongs are angled toward each other and toward the central axis, the two prongs having a first side adjacent the curved segment and a second side adjacent the second portion, the first sides of the two prongs being disposed further apart than the second sides of the two prongs.
  • 2. The nasal cannula of claim 1, wherein the second end of the body part is disposed opposite to the first end of the body part and, when the prong part is connected to the body part, each of the two prongs extend from the prong part along a first axis that is substantially parallel to a second axis extending from the first end of the body part to the second end of the body part.
  • 3. The nasal cannula of claim 1 further comprising first and second headgear extensions on the body part and a headgear strap coupled to the body part at the first and second headgear extensions, the first and second headgear extensions being disposed on left and right sides of the user-side portion respectively.
  • 4. The nasal cannula of claim 1, wherein each of the two prongs comprises a flange proximate, but spaced from, its end, wherein the flange is configured to cause sealing of the respective prong in an associated nare of a user in use.
  • 5. The nasal cannula of claim 1, wherein the second end of the body part is configured to be coupled to the conduit.
  • 6. The nasal cannula of claim 1, wherein the first end, the second end, and the two prongs of the prong part is made of a single piece of silicone.
  • 7. The nasal cannula of claim 1, wherein the body part is made of a rigid plastic material.
  • 8. The nasal cannula of claim 1, wherein the body part comprises a plurality of apertures configured to externally vent gases exhaled by the user through the nares of the user, the plurality of apertures facing away from a user's face in use.
  • 9. A nasal cannula configured to deliver humidified gases to a user, the nasal cannula comprising: a prong part comprising: a prong part body having a first end with two openings, a second end with a single opening, and an outer surface extending between the two openings of the first end and the single opening of the second end and having at least a curved user-side portion facing toward a user's face in use, the user-side portion curving inwardly toward an interior of the prong part body; andtwo prongs extending from and integrally formed with the first end of the prong part body, the two prongs being angled toward each other, each of the two prongs having a first side adjacent the user-side portion and a second side opposite the first side, the first sides of the two prongs being disposed further apart than the second sides of the two prongs,the prongs being spaced from each other and being shaped to fit within corresponding nares of a user to deliver the gases thereto in use, andthe second end of the prong part body being disposed opposite to the first end and being configured to receive the humidified gases.
  • 10. The nasal cannula of claim 9, wherein the prong part is made of silicone and is configured to be coupled to a more rigid body part.
  • 11. The nasal cannula of claim 9 further comprising a body part having a first end and a second end, wherein the second end of the prong part is configured to be connected to the first end of the body part, the second end of the body part being configured to be coupled to a conduit configured to supply humidified gases to the nasal cannula, and air flowing through the body part being in the same direction as the prongs extend from the prong part body, the body part further comprising an outer surface having at least a curved user-side portion facing toward the user's face in use, the user-side portion curving inward toward an interior of the body part.
  • 12. The nasal cannula of claim 11, wherein the prong part is made of silicone and the body part is made of a more rigid plastic material.
  • 13. The nasal cannula of claim 11, wherein the body part comprises a plurality of apertures configured to externally vent gases exhaled through nares of a user in use, the plurality of apertures facing away from a user's face in use.
  • 14. The nasal cannula of claim 13, wherein the body part comprises a recessed surface, and the plurality of apertures are positioned on the recessed surface.
  • 15. The nasal cannula of claim 9, further comprising a body part configured to be connected to the second end of the prong part and a headgear arrangement configured to maintain the prong part in a position with the two prongs against a user's nares in use, the headgear arrangement comprising first and second headgear extensions and a headgear strap, the first headgear extension having a distal end connected to a left peripheral side of the body part on a distal side of the prong part at a location spaced from a user in use, and a proximal end disposed proximally toward a left side of a user's face in use.
  • 16. The nasal cannula of claim 15, wherein the first headgear extension comprises a first portion and a second portion, the first portion of the first headgear extension comprising the distal end of the first headgear extension and extending at least along a first lateral direction extending laterally away from the left peripheral side of the body part and beyond an outer periphery of the prong part.
  • 17. The nasal cannula of claim 16, wherein the second portion of the first headgear extension extends from the first portion, along a second direction extending more proximally toward a user in use than the first direction in use, the second headgear extension having a distal end connected to a right peripheral side of the body part on the distal side of the prong part at a location spaced from a user in use, and a proximal end disposed proximally toward a right side of a user's face in use.
  • 18. The nasal cannula of claim 17, wherein the second headgear extension comprises a first portion and a second portion, the first portion of the second headgear extension comprising the distal end of the second headgear extension and extending at least along a third lateral direction extending laterally away from the body part and beyond the outer periphery of the prong part, the second portion of the second headgear extension extending from the first portion, along a fourth direction extending more proximally toward the user than the third direction in use.
  • 19. The nasal cannula of claim 18, wherein the first portion of the first headgear extension and the first portion of the second headgear extension extend laterally outward distally of a sealing location between the prong part and the body part and the second portion of the first headgear extension and the second portion of the second headgear extension terminate proximally of the sealing location between the prong part and the body part.
  • 20. The nasal cannula of claim 9, further comprising a body part, an outlet of the body part configured to be connected to the second end of the prong part, wherein a horizontal direction of the body part extends from an inlet of the body part toward the two prongs, and a vertical direction extends perpendicular to the horizontal direction, wherein an outer surface of the body part comprises at least a left side curved portion and a right side curved portion, the left side curved portion comprising a left side apex and the right side curved portion comprising a right side apex, the outer surface having a first height along the vertical direction at a location between the left side apex and the right side apex, the nasal cannula further comprising: a first headgear extension having a first end, the first end of the headgear extension attached to the left side apex, the first end of the first headgear extension having a second height along the vertical direction at a connection between the first end and the left side apex; anda second headgear extension having a first end attached to the right side apex, the first end of the second headgear extension having a third height along the vertical direction at the connection between the first end of the second headgear extension and the right side apex, wherein the second and third heights are smaller than the first height.
  • 21. The nasal cannula of claim 20, wherein the first height is at a location between the left side curved portion and the right side curved portion.
  • 22. The nasal cannula according to claim 9 additionally comprising a more rigid body part comprising an extension, wherein the second end of the prong body part sealingly engages the extension, when assembled.
  • 23. The nasal cannula of claim 9 additionally comprising a more rigid body part comprising a first end and a second end, the first end comprising a partial spherical opening configured to engage a ball jointed connector and wherein the second end of the more rigid body part comprising an extension configured to sealingly engage the second end of the prong body part.
  • 24. The nasal cannula of claim 23, wherein a maximum dimension of the partially spherical opening is larger than an internal height of the extension.
  • 25. The nasal cannula of claim 9, wherein the two openings are disposed on proximal ends of the two prongs and are oval in shape and angled toward one another such that angles are formed between midlines of said openings.
  • 26. The nasal cannula of claim 25, wherein the curved user-side portion includes an apex, and an axis defined through said apex intersects with the midlines at a position that is exterior to the prong part body.
  • 27. The nasal cannula of claim 26, wherein the curved user-side portion is positioned between the midlines.
  • 28. The nasal cannula of claim 9 additionally comprising a more rigid body connected to the prong part body and having a distal end, the distal end of the more rigid body comprising an external surface that is a partially spherical.
Priority Claims (2)
Number Date Country Kind
531332 Feb 2004 NZ national
534606 Aug 2004 NZ national
US Referenced Citations (392)
Number Name Date Kind
301111 Genese Jul 1884 A
472238 Van Orden Apr 1892 A
577926 Miller Mar 1897 A
718470 Jones Jan 1903 A
751091 Moran Feb 1904 A
770013 Linn Sep 1904 A
1635545 Drager Jul 1927 A
2126755 Dreyfus Aug 1938 A
2228218 Schwartz Jan 1941 A
2296150 Dockson et al. Sep 1942 A
2353643 Bulbulian Jul 1944 A
2359506 Battley et al. Oct 1944 A
2388604 Eisenbud Nov 1945 A
2452845 Fisher Nov 1948 A
2508050 Valente May 1950 A
2693800 Caldwell Nov 1954 A
2738788 Matheson et al. Mar 1956 A
2843121 Hudson Jul 1958 A
2859748 Hudson Nov 1958 A
2939458 Lundquist Jun 1960 A
3424633 Corrigall et al. Jan 1969 A
3490452 Greenfield Jan 1970 A
3599635 Kenneth Aug 1971 A
3682171 Dali Aug 1972 A
3850171 Ball et al. Nov 1974 A
3972321 Proctor Aug 1976 A
3977432 Vidal Aug 1976 A
3992720 Nicolinas Nov 1976 A
4090510 Segersten May 1978 A
D250047 Lewis et al. Oct 1978 S
D250131 Lewis et al. Oct 1978 S
4150464 Tracy Apr 1979 A
D252322 Johnson Jul 1979 S
4201205 Bartholomew May 1980 A
4258710 Reber Mar 1981 A
4266540 Panzik et al. May 1981 A
4278082 Blackmer Jul 1981 A
4354488 Bartos Oct 1982 A
4367735 Dali Jan 1983 A
4378011 Wamcke et al. Mar 1983 A
4437462 Piljay Mar 1984 A
4454880 Muto et al. Jun 1984 A
4621632 Bartels Nov 1986 A
4676241 Webb et al. Jun 1987 A
D293613 Wingler Jan 1988 S
4753233 Grimes Jun 1988 A
4782832 Trimble et al. Nov 1988 A
4836200 Clark et al. Jun 1989 A
4856508 Tayebi Aug 1989 A
4915104 Marcy Apr 1990 A
4915105 Lee Apr 1990 A
4919128 Kopala et al. Apr 1990 A
4941467 Takata Jul 1990 A
4944310 Sullivan Jul 1990 A
D310431 Bellm Sep 1990 S
4971051 Toffolon Nov 1990 A
4986269 Hakkinen Jan 1991 A
5010925 Atkinson et al. Apr 1991 A
5016625 Hsu et al. May 1991 A
5042478 Kopala Aug 1991 A
D320677 Kumagai et al. Oct 1991 S
D321419 Wallace Nov 1991 S
5062421 Burns et al. Nov 1991 A
5065756 Rapoport Nov 1991 A
D322318 Sullivan Dec 1991 S
5074297 Venegas Dec 1991 A
5094236 Tayebi Mar 1992 A
5113857 Dickerman et al. May 1992 A
5148802 Sanders et al. Sep 1992 A
5164652 Johnson et al. Nov 1992 A
5231979 Rose et al. Aug 1993 A
5243971 Sullivan et al. Sep 1993 A
5245995 Sullivan et al. Sep 1993 A
D340317 Cole Oct 1993 S
5259377 Schroeder Nov 1993 A
5269296 Landis Dec 1993 A
5349949 Schegerin Sep 1994 A
D354128 Rinehart Jan 1995 S
D355484 Rinehart Feb 1995 S
5400776 Bartholomew Mar 1995 A
5429683 Le Mitouard Jul 1995 A
5449234 Gipp et al. Sep 1995 A
5458202 Fellows et al. Oct 1995 A
5477852 Landis et al. Dec 1995 A
5513634 Jackson May 1996 A
5533506 Wood Jul 1996 A
5542128 Lomas Aug 1996 A
5551419 Froehlich et al. Sep 1996 A
5558090 James Sep 1996 A
5570689 Starr et al. Nov 1996 A
5588423 Smith Dec 1996 A
5595174 Gwaltney Jan 1997 A
5601078 Schaller et al. Feb 1997 A
D378610 Reischel et al. Mar 1997 S
5649532 Griffiths Jul 1997 A
5657752 Landis et al. Aug 1997 A
5662101 Ogden et al. Sep 1997 A
5664566 Mcdonald et al. Sep 1997 A
5690097 Howard et al. Nov 1997 A
5724965 Handke et al. Mar 1998 A
5752510 Goldstein May 1998 A
5755578 Contant et al. May 1998 A
5806727 Joseph Sep 1998 A
5746201 Kidd Dec 1998 A
5857460 Popitz Jan 1999 A
5884624 Barnett et al. Mar 1999 A
5904278 Barlow et al. May 1999 A
5921239 McCall et al. Jul 1999 A
5941245 Hannah et al. Aug 1999 A
5943473 Levine Aug 1999 A
5953763 Gouget Sep 1999 A
6016804 Gleason et al. Jan 2000 A
6017315 Starr et al. Jan 2000 A
6019101 Cotner et al. Feb 2000 A
6039044 Sullivan Mar 2000 A
6050260 Daniell et al. Apr 2000 A
6112746 Kwok et al. Sep 2000 A
6119693 Kwok et al. Sep 2000 A
6119694 Correa et al. Sep 2000 A
6135109 Blasdell et al. Oct 2000 A
6135432 Hebblewhite et al. Oct 2000 A
6192886 Rudolph Feb 2001 B1
D440302 Wolfe Apr 2001 S
6272933 Gradon Aug 2001 B1
6298850 Argraves Oct 2001 B1
6302105 Wickham et al. Oct 2001 B1
6341606 Bordewick et al. Jan 2002 B1
6347631 Hansen et al. Feb 2002 B1
D455891 Biedrzycki Apr 2002 S
6398197 Dickinson et al. Jun 2002 B1
6412488 Barnett et al. Jul 2002 B1
6418928 Bordewick et al. Jul 2002 B1
6427694 Hecker et al. Aug 2002 B1
6431172 Bordewick Aug 2002 B1
6435181 Jones, Jr. et al. Aug 2002 B1
6439234 Curti et al. Aug 2002 B1
6457473 Brostrom et al. Oct 2002 B1
6467483 Kopacko et al. Oct 2002 B1
6478026 Wood Nov 2002 B1
6484725 Chi Nov 2002 B1
6488664 Solomon et al. Dec 2002 B1
6491034 Gunaratnam et al. Dec 2002 B1
6513526 Kwok et al. Feb 2003 B2
6526978 Dominguez Mar 2003 B2
6561188 Ellis May 2003 B1
6561190 Kwok May 2003 B1
6561191 Kwok May 2003 B1
6581594 Drew et al. Jun 2003 B1
6581601 Ziaee Jun 2003 B2
6588424 Bardel Jul 2003 B2
6631718 Lovell Oct 2003 B1
6637434 Noble Oct 2003 B2
6644315 Ziaee Nov 2003 B2
6651658 Hill et al. Nov 2003 B1
6651663 Barnett et al. Nov 2003 B2
6659102 Sico Dec 2003 B1
6662803 Gradon et al. Dec 2003 B2
6668828 Figley et al. Dec 2003 B1
6679257 Robertson et al. Jan 2004 B1
6679265 Strickland et al. Jan 2004 B2
6691707 Gunaratnam et al. Feb 2004 B1
6712072 Lang Mar 2004 B1
6772761 Rucker, Jr. Aug 2004 B1
6796308 Gunaratnam et al. Sep 2004 B2
6817362 Gelinas et al. Nov 2004 B2
6823869 Raje et al. Nov 2004 B2
6851425 Jaffre et al. Feb 2005 B2
6892729 Smith et al. May 2005 B2
6895965 Scarberry et al. May 2005 B2
6907882 Ging et al. Jun 2005 B2
6918390 Lithgow et al. Jul 2005 B2
6951218 Gradon et al. Oct 2005 B2
6953354 Edirisuriya et al. Oct 2005 B2
7004165 Salcido Feb 2006 B1
7007696 Palkon et al. Mar 2006 B2
7021311 Gunaratnam et al. Apr 2006 B2
D520140 Chaggares May 2006 S
7066179 Eaton et al. Jun 2006 B2
7077126 Kummar et al. Jul 2006 B2
D526094 Chen Aug 2006 S
7096864 Mayer et al. Aug 2006 B1
D533269 McAuley et al. Dec 2006 S
7178525 Matula, Jr. et al. Feb 2007 B2
7201169 Wilkie Apr 2007 B2
7207333 Tohara Apr 2007 B2
7210481 Lovell et al. May 2007 B1
7219669 Lovell et al. May 2007 B1
7225811 Ruiz et al. Jun 2007 B2
7290546 Sprinkle et al. Nov 2007 B2
7318437 Gunaratnam et al. Jan 2008 B2
7353827 Geist Apr 2008 B2
7406966 Wondka et al. Aug 2008 B2
7448386 Ho et al. Nov 2008 B2
7523754 Lithgow et al. Apr 2009 B2
D595841 McAuley et al. Jul 2009 S
7665464 Kopacko et al. Feb 2010 B2
7694677 Tang Apr 2010 B2
7753051 Burrow et al. Jul 2010 B2
7814911 Bordewick et al. Oct 2010 B2
7827990 Melidis et al. Nov 2010 B1
7896003 Matula et al. Mar 2011 B2
8042539 Chandran et al. Oct 2011 B2
8136524 Ging et al. Mar 2012 B2
8136525 Lubke et al. Mar 2012 B2
D661796 Andrews et al. Jun 2012 S
8371302 Ging et al. Feb 2013 B2
8443807 McAuley et al. May 2013 B2
D686313 Matula et al. Jul 2013 S
8479741 McAuley et al. Jul 2013 B2
8567404 Davidson et al. Oct 2013 B2
8631793 Omura et al. Jan 2014 B2
8636005 Gradon et al. Jan 2014 B2
8701667 Ho et al. Apr 2014 B1
8714157 McAuley et al. May 2014 B2
8757157 Price et al. Jun 2014 B2
8783257 McAuley et al. Jul 2014 B2
8944061 D'souza et al. Feb 2015 B2
8950404 Formica et al. Feb 2015 B2
8960196 Henry Feb 2015 B2
9027556 Ng et al. May 2015 B2
9032955 Lubke et al. May 2015 B2
9072852 McAuley et al. Jul 2015 B2
9119931 D'Souza et al. Sep 2015 B2
9138555 McAuley et al. Sep 2015 B2
9149596 Valcic et al. Oct 2015 B2
9242062 Melidis et al. Jan 2016 B2
9320566 Alston, Jr. et al. Apr 2016 B1
9333315 McAuley et al. May 2016 B2
9339624 McAuley et al. May 2016 B2
9375545 Darkin et al. Jun 2016 B2
9381316 Ng et al. Jul 2016 B2
9439405 Bruggemann et al. Sep 2016 B2
9517317 McAuley et al. Dec 2016 B2
9522246 Frater et al. Dec 2016 B2
9561339 McAuley et al. Feb 2017 B2
20010017134 Bahr Aug 2001 A1
20010020474 Hecker et al. Sep 2001 A1
20020020416 Namey Feb 2002 A1
20020026934 Lithgow et al. Mar 2002 A1
20020029780 Frater et al. Mar 2002 A1
20020046755 Voss Apr 2002 A1
20020053347 Ziaee May 2002 A1
20020059935 Wood May 2002 A1
20020096178 Ziaee Jul 2002 A1
20020108613 Gunaratnam et al. Aug 2002 A1
20030005509 Kelzer Jan 2003 A1
20030005931 Jaffre et al. Jan 2003 A1
20030005933 Izuchukwu Jan 2003 A1
20030019495 Palkon et al. Jan 2003 A1
20030019496 Kopacko et al. Jan 2003 A1
20030029454 Gelinas et al. Feb 2003 A1
20030047185 Olsen et al. Mar 2003 A1
20030075182 Heidmann et al. Apr 2003 A1
20030079749 Strickland et al. May 2003 A1
20030089373 Gradon et al. May 2003 A1
20030094177 Smith et al. May 2003 A1
20030121519 Estes et al. Jul 2003 A1
20030164170 Drew et al. Sep 2003 A1
20030172936 Wilkie et al. Sep 2003 A1
20030196655 Ging et al. Oct 2003 A1
20030196656 Moore Oct 2003 A1
20030196658 Ging et al. Oct 2003 A1
20030196659 Gradon et al. Oct 2003 A1
20030196664 Jacobson Oct 2003 A1
20030200970 Stenzler Oct 2003 A1
20040025882 Madaus et al. Feb 2004 A1
20040065328 Amarasinghe et al. Apr 2004 A1
20040067333 Amarasinghe Apr 2004 A1
20040107968 Griffiths Jun 2004 A1
20040118406 Lithgow et al. Jun 2004 A1
20040139973 Wright Jul 2004 A1
20040149280 Semeniuk Aug 2004 A1
20040182398 Sprinkle et al. Sep 2004 A1
20040211427 Jones et al. Oct 2004 A1
20040226566 Gunaratnam et al. Nov 2004 A1
20040255949 Lang et al. Dec 2004 A1
20050011524 Thomlinson Jan 2005 A1
20050016532 Farrell Jan 2005 A1
20050028822 Sleeper et al. Feb 2005 A1
20050033247 Thompson Feb 2005 A1
20050045182 Wood et al. Mar 2005 A1
20050051177 Wood Mar 2005 A1
20050066976 Wondka Mar 2005 A1
20050076913 Ho et al. Apr 2005 A1
20050092327 Fini et al. May 2005 A1
20050098183 Nash et al. May 2005 A1
20050121037 Wood Jun 2005 A1
20050150497 Eifler et al. Jul 2005 A1
20050155604 Ging et al. Jul 2005 A1
20050199242 Matula Sep 2005 A1
20050205096 Matula et al. Sep 2005 A1
20050235999 Wood et al. Oct 2005 A1
20060032504 Burton et al. Feb 2006 A1
20060042629 Geist Mar 2006 A1
20060042632 Bishop et al. Mar 2006 A1
20060060200 Ho et al. Mar 2006 A1
20060081256 Palmer Apr 2006 A1
20060096598 Ho et al. May 2006 A1
20060107958 Sleeper May 2006 A1
20060118117 Berthon-Jones et al. Jun 2006 A1
20060124131 Chandran Jun 2006 A1
20060130844 Ho et al. Jun 2006 A1
20060137690 Gunaratnam et al. Jun 2006 A1
20060174887 Chandran et al. Aug 2006 A1
20060196511 Lau et al. Sep 2006 A1
20060201514 Jones et al. Sep 2006 A1
20060237017 Davidson et al. Oct 2006 A1
20060237018 McAuley et al. Oct 2006 A1
20060254593 Chang Nov 2006 A1
20060266361 Hernandez Nov 2006 A1
20060283461 Lubke et al. Dec 2006 A1
20070000492 Hansel et al. Jan 2007 A1
20070010786 Casey et al. Jan 2007 A1
20070044804 Matula et al. Mar 2007 A1
20070089749 Ho et al. Apr 2007 A1
20070125385 Ho et al. Jun 2007 A1
20070125387 Zollinger et al. Jun 2007 A1
20070137653 Wood Jun 2007 A1
20070142785 Lundgaard et al. Jun 2007 A1
20070157353 Guney et al. Jul 2007 A1
20070163600 Hoffman Jul 2007 A1
20070174952 Jacob Aug 2007 A1
20070175480 Gradon et al. Aug 2007 A1
20070209663 Marque et al. Sep 2007 A1
20070215161 Frater et al. Sep 2007 A1
20070221227 Ho Sep 2007 A1
20070227541 Van Den Oct 2007 A1
20070267017 McAuley et al. Nov 2007 A1
20070295335 Nashed Dec 2007 A1
20080041388 McAuley et al. Feb 2008 A1
20080041393 Bracken Feb 2008 A1
20080047560 Veliss et al. Feb 2008 A1
20080060648 Thornton et al. Mar 2008 A1
20080060657 McAuley et al. Mar 2008 A1
20080099024 Gunaratnam et al. May 2008 A1
20080105257 Klasek et al. May 2008 A1
20080110464 Davidson et al. May 2008 A1
20080142019 Lewis Jun 2008 A1
20080178875 Henry Jul 2008 A1
20080190432 Blochlinger et al. Aug 2008 A1
20080190436 Jaffe et al. Aug 2008 A1
20080196728 Ho Aug 2008 A1
20080236586 Mcdonald et al. Oct 2008 A1
20080264422 Fishman Oct 2008 A1
20080314388 Brambilla et al. Dec 2008 A1
20090014007 Brambilla et al. Jan 2009 A1
20090044808 Guney et al. Feb 2009 A1
20090107504 McAuley et al. Apr 2009 A1
20090120442 Ho May 2009 A1
20090133697 Kwok et al. May 2009 A1
20090145429 Ging et al. Jun 2009 A1
20090173349 Hernandez et al. Jul 2009 A1
20100000538 Edwards et al. Jan 2010 A1
20100051031 Lustenberger et al. Mar 2010 A1
20100083961 McAuley et al. Apr 2010 A1
20100108072 D'souza et al. May 2010 A1
20100154798 Henry et al. Jun 2010 A1
20100170516 Grane Jul 2010 A1
20100258132 Moore Oct 2010 A1
20100258136 Doherty et al. Oct 2010 A1
20100307502 Rummery et al. Dec 2010 A1
20100313891 Veliss et al. Dec 2010 A1
20100319700 Ng et al. Dec 2010 A1
20110072553 Ho Mar 2011 A1
20110146685 Allan et al. Jun 2011 A1
20110265796 Amarasinghe et al. Nov 2011 A1
20110308520 McAuley et al. Dec 2011 A1
20120125339 Ho et al. May 2012 A1
20120132209 Rummery May 2012 A1
20120285457 Mansour et al. Nov 2012 A1
20120304999 Swift et al. Dec 2012 A1
20120318270 McAuley et al. Dec 2012 A1
20130152918 Rummery et al. Jun 2013 A1
20130160769 Ng et al. Jun 2013 A1
20140083428 Rothermel et al. Mar 2014 A1
20140083430 Matula, Jr. et al. Mar 2014 A1
20140137870 Barlow et al. May 2014 A1
20150013678 McAuley Jan 2015 A1
20150033457 Tryner et al. Feb 2015 A1
20150090266 Melidis et al. Apr 2015 A1
20150297855 McAuley et al. Oct 2015 A1
20150374946 McAuley et al. Dec 2015 A1
20160008558 Huddart et al. Jan 2016 A1
20160038705 McAuley et al. Feb 2016 A1
20160038706 McAuley et al. Feb 2016 A1
20160038707 Allan et al. Feb 2016 A1
20160166792 Allan et al. Jun 2016 A1
20170072155 Allan et al. Mar 2017 A1
20170119988 Allan et al. May 2017 A1
20170239438 McAuley et al. Aug 2017 A1
20170304574 McAuley et al. Oct 2017 A1
20170326324 McAuley et al. Nov 2017 A1
Foreign Referenced Citations (94)
Number Date Country
131 16 62 Dec 1992 CA
217 253 8 Jul 1994 CN
1784250 Jun 2006 CN
1901961 Jan 2007 CN
1988930 Jun 2007 CN
101214402 Jul 2008 CN
101541380 Sep 2009 CN
895692 Nov 1953 DE
19603949 Nov 1998 DE
10312881 May 2004 DE
102006011151 Sep 2007 DE
0747078 Dec 1996 EP
1 582 231 Oct 2005 EP
1488820 Sep 2009 EP
2 130 563 Dec 2009 EP
1646910 Aug 2015 EP
2658725 Aug 1991 FR
2749176 Dec 1997 FR
190 224 431 Dec 1902 GB
880 824 Oct 1961 GB
979357 Jan 1965 GB
1 467 828 Mar 1977 GB
2133275 Jul 1984 GB
2186801 Aug 1987 GB
2173274 Dec 1997 GB
H09-010311 Jan 1997 JP
2000-325481 Nov 2000 JP
2004-016488 Jan 2004 JP
2005-529687 Oct 2005 JP
2007-516750 Jun 2007 JP
2007-527271 Sep 2007 JP
WO 199804310 Feb 1998 WO
WO 199804311 Feb 1998 WO
WO 98018514 May 1998 WO
WO 199857691 Dec 1998 WO
WO 9904842 Feb 1999 WO
WO 99058181 Nov 1999 WO
WO 2000050122 Aug 2000 WO
WO 2000057942 Oct 2000 WO
WO 2000069497 Nov 2000 WO
WO 2000074758 Dec 2000 WO
WO 2000078384 Dec 2000 WO
WO 2001000266 Jan 2001 WO
WO 0132250 May 2001 WO
WO 0141854 Jun 2001 WO
WO 01058293 Aug 2001 WO
WO 2001062326 Aug 2001 WO
WO 0197892 Dec 2001 WO
WO 02005883 Jan 2002 WO
WO 2002047749 Jun 2002 WO
WO 02074372 Sep 2002 WO
WO 2003035156 May 2003 WO
WO 2004007010 Jan 2004 WO
WO 2004022147 Mar 2004 WO
WO 2004041341 May 2004 WO
WO 2004041342 May 2004 WO
WO 2004073778 Sep 2004 WO
WO 2005021075 Mar 2005 WO
WO 2005051468 Jun 2005 WO
WO 2005079726 Sep 2005 WO
WO 2005086946 Sep 2005 WO
WO 2005123166 Dec 2005 WO
WO 2006000046 Jan 2006 WO
WO 06050559 May 2006 WO
WO 2006069415 Jul 2006 WO
WO 2006074515 Jul 2006 WO
WO 2006096924 Sep 2006 WO
WO 2006130903 Dec 2006 WO
WO 2007006089 Jan 2007 WO
WO 2007022562 Mar 2007 WO
WO 2007041751 Apr 2007 WO
WO 2007041786 Apr 2007 WO
WO 2007045008 Apr 2007 WO
WO 2007048174 May 2007 WO
WO 2007147088 Dec 2007 WO
WO 2008007985 Jan 2008 WO
WO 2008030831 Mar 2008 WO
WO 2008060295 May 2008 WO
WO 2008068966 Jun 2008 WO
WO 2008070929 Jun 2008 WO
WO 2008106716 Sep 2008 WO
WO 2008148086 Dec 2008 WO
WO 2009026627 Mar 2009 WO
WO 2009052560 Apr 2009 WO
WO 2009059353 May 2009 WO
WO 2009092057 Jul 2009 WO
WO 2009139647 Nov 2009 WO
WO 2010066004 Jun 2010 WO
WO 2011014931 Feb 2011 WO
WO 2011059346 May 2011 WO
WO 2012052902 Apr 2012 WO
WO 2015033287 Mar 2015 WO
WO 2017049356 Mar 2017 WO
WO 2017049357 Mar 2017 WO
Non-Patent Literature Citations (97)
Entry
International Preliminary Report on Patentability (IPRP), International Application No. PCT/NZ2009/000219, dated Apr. 12, 2011, 9 pages.
International Search Report, International Application No. PCT/NZ2009/000219, dated Feb. 2, 2010, 3 pages.
English Translation of Chinese Examination Report; Application No. 2007800266164; 5 pages.
English Translation of First Office Action for Chinese Application No. 201210080441.8 dated Mar. 24, 2014, in 4 pages.
Examination Report; Australian Application No. 2007273324; dated May 22, 2012; 3 pages.
International Search Report for International Application No. PCT/NZ2007/000185, dated Oct. 31, 2007, in 3 pages.
International Search Report for International Application No. PCT/NZ2014/000021; filed dated May 20, 2014.
Second Chinese Office Action for Chinese Patent Application No. 201210080441.8 dated Dec. 1, 2014 in 11 pages (with English translation).
Australian Examination Report for Patent Application No. 2012265597 dated Dec. 19, 2013, in 5 pages.
Canadian Examination Report for Application No. 2655839 dated Oct. 4, 2013, in 2 pages.
English Translation of Chinese Examination Report; Chinese Application No. 2007800266164; 5 pages.
International Search Report; PCT/NZ2009/000072; dated Jul. 28, 2009; 4 pages.
UK Search and Examination Report; dated Mar. 14, 2013; Application No. GB1210075.6; 2 pages.
UK Examination Report; dated May 9, 2013; Application No. GB1119385.1; 4 pages.
Australian Examination Report; dated Mar. 4, 2014; Application No. 2010246985; 5 pages.
English Translation of JP Examination Report; dated Feb. 10, 2014; Application No. 2012-510418; 4 pages.
Chinese Examination Report; dated Mar. 27, 2014; Chinese Application No. 201080028029.0; 16 pages.
GB Combined Search and Examination Report; dated May 7, 2014; Application No. GB1406402.6; 6 pages.
GB Combined Search and Examination Report; dated May 7, 2014; Application No. GB1406401.8; 4 pages.
JP Examination Report, Application No. 2012-538784; 3 pages.
Australian Examination Report; dated Aug. 14, 2015; Application No. 2015202814; 8 pages.
Chinese Examination Report; dated Jul. 17, 2015; Application No. 201080061122.1; 10 pages.
Chinese Examination Report; dated Sep. 14, 2015; Application No. 201080028029.0; 3 pages.
European Extended Search Report; dated Sep. 4, 2015; Application No. 10830251.4; 7 pages.
European Extended Search Report; dated Sep. 8, 2015; Application No. 10774623.2; 7 pages.
Japanese Examination Report; dated Jul. 22, 2015; Application No. 2015-098324; 8 pages.
Japanese Examination Report; dated Aug. 5, 2015; Application No. 2012-538784; 8 pages.
Australian Examination Report; dated Sep. 28, 2016; Application No. 2010241390; 4 pages.
English Translation of Chinese Examination Report; dated Sep. 3, 2014; Application No. 201080061122.1; 9 pages.
Second Chinese Office Action; dated Jan. 19, 2015; Application No. 201080028029.0; 16 pages.
EPO Search Report; dated Apr. 2, 2014; Application No. 09819444.2; 8 pages.
Australian Examination Report; dated Aug. 5, 2016; Application No. 2016204384; 2 pages.
Australian Examination Report; Application No. 20015201920; dated Jul. 20, 2015; 3 pages.
European Examination Report; Application No. 07808683.2; dated Jul. 8, 2015; 8 pages.
Canadian Examination Report; Application No. 2890556; dated Jan. 27, 2016; 3 pages.
Third Chinese Office Action; Application No. 201080061122.1; dated Apr. 1, 2016; 5 pages.
European Search Report and Written Opinion dated May 12, 2016; 11 pages.
Canadian Office Action; Application No. 2,780,310; dated Jul. 26, 2016; 4 pages.
Japanese Office Action; Application No. 2012-538784; dated Jul. 25, 2016; 2 pages.
Canadian Office Action; Application No. 2918167; dated Oct. 3, 2016; 4 pages.
Declaration of Dr. John Izuchukwu, Ph.D., P.E., U.S. Pat. No. 8,479,741, IPR Nos. 2016-1714 & 2016-1718.
Declaration of Dr. John Izuchukwu, Ph.D., P.E., U.S. Pat. No. 8,443,807, IPR Nos. 2016-1726 & 2016-1734.
File History of U.S. Pat. No. 8,443,807 to McAuley et al.
File History of U.S. Pat. No. 8,479,741 to McAuley et al.
Fisher & Paykel MR810 Manual, Rev. C.
Fisher & Paykel HC200 Series Nasal CPAP Blower & Heated Humidifier User Manual.
HomeDepot.com—Ring Nut Sales Page (Retrieved Oct. 16, 2015 from http://www.homedepot.com/p/Everbilt-1-2-in-Galvanized-HexNut-804076/204647893).
Malloy, Plastic Part Design for Injection Molding (1994).
Merriam-Webster's Collegiate Dictionary, Eleventh Edition (2004) (selected portions).
Patent Owner's Complaint for Fisher & Paykel Healthcare Ltd. v. ResMed Corp., Case No. 3:16-cv-02068-GPC-WVG (S.D. Cal.).
Patent Owner's Complaint for Fisher & Paykel Healthcare Ltd. v. ResMed Corp., Case No. 2:16-cv-06099-R-AJW (C.D. Cal.).
Patent Owner's Notice of Voluntary Dismissal Without Prejudice for Fisher & Paykel Healthcare Ltd. v. ResMed Corp., Case No. 2:16-cv-06099-R-AJW (C.D. Cal.).
Petitioners' Complaint for ResMed Inc., et al. v. Fisher & Paykel Healthcare Corp. Ltd., et al., Case No. 3:16-cv-02072-JAH-MDD (S.D. Cal.).
Petitioners' Notice of Voluntary Dismissal Without Prejudice for ResMed Inc., et al. v. Fisher & Paykel Healthcare Corp. Ltd., et al., Case No. 3:16-cv-02072-JAH-MDD (S.D. Cal.).
Petition for Inter Partes Review of U.S. Pat. No. 8,479,741 Pursuant to 35 U.S.C. §§ 311-19, 37 C.F.R. § 42, IPR2016-01714.
Petition for Inter Partes Review of U.S. Pat. No. 8,479,741 Pursuant to 35 U.S.C. §§ 311-19, 37 C.F.R. § 42, IPR2016-01718.
Petition for Inter Partes Review of U.S. Pat. No. 8,443,807 Pursuant to 35 U.S.C. §§ 311-19, 37 C.F.R. § 42, IPR2016-01726.
Petition for Inter Partes Review of U.S. Pat. No. 8,443,807 Pursuant to 35 U.S.C. §§ 311-19, 37 C.F.R. § 42, IPR2016-01734.
ResMed FlexiFit web pages (Wayback Machine).
ResMed Webpage from Jun. 29, 1997 (Source: Wayback Machine Internet Archive); http://web.archive.org/web/19970629053430/http://www.resmed.com/maskframes/mask.htm.
ResMed “Mirage Swift™ Nasal Pillows System from ResMed” publication, ©2004 ResMed Ltd.
ResMed “Mirage Swift™ Nasal Pillows System: User's Guide” publication, ©2004 ResMed Ltd.
ResMed “Mirage Vista™ Nasal Mask: Components Card” publication, ©2005 ResMed Ltd.
ResMed Origins Brochure (Retrieved Apr. 17, 2016 from http://www.resmed.com/us/dam/documents/articles/resmedorigins.pdf).
ResMed Ultra Mirage brochure.
ResMed Ultra Mirage web pages (Wayback Machine).
Statutory Declaration made by Alistair Edwin McAuley, Apr. 9, 2015, in the matter of an Opposition by Fisher & Paykel Healthcare Limited of Australian patent application 2009221630 in the name of ResMed Limited.
The American Heritage Dictionary of the English Language, Fourth Edition (2006) (selected portions).
WeddingBands.com—Men's Wedding Ring Shopping Page (Retrieved Oct. 16, 2015 from http://www.weddingbands.com/ProductPop_wedding_bands_metal/4 8214W.html).
International Search Report; PCT/NZ2010/000229; dated Mar. 18, 2011; 9 pages.
Written Opinion of the International Searching Authority; PCT/NZ2010/000229; dated Mar. 18, 2011; 13 pages.
International Preliminary Report on Patentability and Written Opinion of the ISA; International Application No. PCT/NZ2010/000229; dated May 22, 2012; 14 pages.
International Search Report; Application No. PCT/NZ2013/000138; dated Dec. 4, 2013; 7 pages.
Philips Respironics “System One Heated Humidifier-User Manual”, 2011, pp. 1-16, [retrivied on Nov. 25, 2013] from the internet: URL: http://www.cpapxchange.com/cpap-machines-biap-machines/system-one-60-series-cpap-humidifier-manual.pdf front cover, pp. 3-4 and 6.
International Search Report; PCT/NZ2005/000062; dated May 27, 2005; 3 pages.
Office Action in corresponding Austrialian Patent Application No. 2016202799, dated May 31, 2016, in 2 pages.
Office Action in corresponding Austrialian Patent Application No. 2016202801, dated Jun. 20, 2016, in 2 pages.
Office Action in corresponding Indian Patent Application No. 5250/KOLNP/2008, dated May 23, 2017, in 8 pages.
Office Action in corresponding European Patent Application No. 09746823.5, dated Apr. 3, 2017, in 2 pages.
Office Action in corresponding Australian Patent Application No. 2017201021, dated Apr. 7, 2017, in 6 pages.
Office Action in corresponding Canadian Patent Application No. 2890556, dated Nov. 28, 2016, in 4 pages.
Fisher & Paykel Interface Solutions Brochure.
Flexifit Brochure, Full Face Delivery—FlexiFit ™431.
Flexifit, Series HC 431 Instructions for Use.
U.S. Appl. No. 61/064,406, 34 pages.
U.S. Appl. No. 61/071,893, 43 pages.
U.S. Appl. No. 61/136,617, 82 pages.
Patent Owner Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,479,741, IPR2016-01714, filed Dec. 14, 2016.
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,479,741 Pursuant to 37 C.F.R. § 42.108, IPR2016-01714, entered Mar. 10, 2017.
Patent Owner Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,479,741, IPR2016-01718, filed Dec. 16, 2016.
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,479,741 Pursuant to 37 C.F.R. § 42.108, IPR2016-01718, entered Mar. 13, 2017.
Patent Owner Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,443,807, IPR2016-01726, filed Dec. 13, 2016.
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,443,807 Pursuant to 37 C.F.R. § 42.108, IPR2016-01726, entered Mar. 6, 2017.
Patent Owner Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,443,807, IPR2016-01734, filed Dec. 22, 2016.
Decision Denying Institution of Inter Partes Review of U.S. Pat. No. 8,443,807 Pursuant to 37 C.F.R. § 42.108, IPR2016-01734, entered Mar. 13, 2017.
First Chinese Office Action for Chinese Patent Application No. 201610116121.1 dated Sep. 28, 2017 in 5 pages.
Australian Examination Report No. 1; dated Oct. 13, 2017; Application No. 2017200991; 3 pages.
Related Publications (1)
Number Date Country
20150013678 A1 Jan 2015 US
Continuations (1)
Number Date Country
Parent 10598026 US
Child 14333134 US